Close
196 notifications closed
The Physiotherapy Board of Australia continued its important work on understanding the physiotherapy workforce in Australia.
The Board focused on a number of initiatives, including the collaborative research with the Australian Physiotherapy Association (APA) on physiotherapist attrition rates. The aim of this research is to help understand why physiotherapists are leaving the profession.
Practitioners were surveyed and interviewed to ascertain the reasons for changing careers or moving away from clinical practice. The results of this research will be published and used to inform the workforce strategic plan into the future.
In addition, the Board, in partnership with the Australian Physiotherapy Council, has been reviewing the process for assessing overseas practitioners to register for practice in Australia and has facilitated more efficient ways of supporting overseas-trained practitioners to become registered in Australia. The Express FLYR Pathway was launched in July 2023 to expedite the Australian registration of practitioners from comparable countries.
The Board, in conjunction with the Physiotherapy Board of New Zealand, revised the bi-national practice thresholds. The focus of the review was to update the key competencies on providing culturally safe care and digital competency, to reflect the increasing reliance on technology to deliver services remotely.
The Board, in partnership with the APA, is exploring the public value of prescribing by physiotherapists.
The Board carried out several activities to investigate the potential risks and benefits of physiotherapy prescribing through analysis, evidence gathering, dialogue and engagement with stakeholders and practitioners.
The Board and the APA formed a national working group, which is made up of physiotherapy practitioners from various clinical settings and areas of expertise, representatives from the APA and the Board, and a number of prescribers and consumers.
The working group is focused on developing a position on physiotherapy prescribing, assessing its potential public value and determining the clinical settings that would be suitable.
Ahpra and the Board are drafting a paper for consultation on the options for registered physiotherapists to be involved in the prescribing of medications.
The Board continued to pursue its engagement with key stakeholders, physiotherapy practitioners and the community. It held Board meetings in Tasmania and Rockhampton, where we met with local health services and practitioners to understand the local health context.
The focus of these visits was to understand the unique challenges of healthcare within rural and remote areas, to hear about innovative approaches to care in the local communities and to discuss any emerging issues.
The stakeholders included local practitioners, representatives from public health services and representatives from regional physiotherapy programs of study.
The Board is committed to keeping abreast of issues relevant to its regulatory mandate such as workforce and protection of the public.
Ms Kim Gibson, Chair